Optimizing Logistics & Cryopreservation of iPSCs to Streamline Product Delivery
Time: 2:00 pm
day: Day Two Track B PM
Details:
- Examining best practices for selecting starting materials, such as donor tissue or reprogramming methods, to ensure the safety and efficacy of iPSC therapies in preclinical research
- Evolving GMP requirements for starting materials used in iPSC therapy development, including considerations for media components and reagents
